Christine Bacharo Villamor, PT | |
3703 W Lake Ave, Suite 200, Glenview, IL 60026-5823 | |
(847) 998-1188 | |
Not Available |
Full Name | Christine Bacharo Villamor |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 3703 W Lake Ave, Glenview, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023283512 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 070.014297 (Illinois) | Primary |
Provider Name | Paxxon Healthcare Services Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1063784148 PECOS PAC ID: 8325959554 Enrollment ID: O20120507000412 |
News Archive
Those who enjoy the caffeinated lift that comes from drinking traditional coffees and teas may tend to overlook the benefits of drinking herbal infusions. Now, as explained in this month's issue of Agricultural Research magazine, the idea that herbal teas may provide a variety of health benefits is no longer just folklore.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 4 days ago
Provider Name | Comprehensive Therapeutics Ltd |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1699094102 PECOS PAC ID: 8921230137 Enrollment ID: O20140422000663 |
News Archive
Those who enjoy the caffeinated lift that comes from drinking traditional coffees and teas may tend to overlook the benefits of drinking herbal infusions. Now, as explained in this month's issue of Agricultural Research magazine, the idea that herbal teas may provide a variety of health benefits is no longer just folklore.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 4 days ago
Provider Name | Onr National Speech Pathology Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1972965952 PECOS PAC ID: 2668463522 Enrollment ID: O20160831002993 |
News Archive
Those who enjoy the caffeinated lift that comes from drinking traditional coffees and teas may tend to overlook the benefits of drinking herbal infusions. Now, as explained in this month's issue of Agricultural Research magazine, the idea that herbal teas may provide a variety of health benefits is no longer just folklore.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 4 days ago
Provider Name | Empowerme Rehabilitation Illinois Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1679098263 PECOS PAC ID: 2365718277 Enrollment ID: O20171020001353 |
News Archive
Those who enjoy the caffeinated lift that comes from drinking traditional coffees and teas may tend to overlook the benefits of drinking herbal infusions. Now, as explained in this month's issue of Agricultural Research magazine, the idea that herbal teas may provide a variety of health benefits is no longer just folklore.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 4 days ago
Provider Name | Empowerme Wellness Kansas City Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1174118103 PECOS PAC ID: 9830504836 Enrollment ID: O20210317001954 |
News Archive
Those who enjoy the caffeinated lift that comes from drinking traditional coffees and teas may tend to overlook the benefits of drinking herbal infusions. Now, as explained in this month's issue of Agricultural Research magazine, the idea that herbal teas may provide a variety of health benefits is no longer just folklore.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Christine Bacharo Villamor, PT 5415 N Sheridan Rd Apt 501, Chicago, IL 60640-1937 Ph: (773) 349-1140 | Christine Bacharo Villamor, PT 3703 W Lake Ave, Suite 200, Glenview, IL 60026-5823 Ph: (847) 998-1188 |
News Archive
Those who enjoy the caffeinated lift that comes from drinking traditional coffees and teas may tend to overlook the benefits of drinking herbal infusions. Now, as explained in this month's issue of Agricultural Research magazine, the idea that herbal teas may provide a variety of health benefits is no longer just folklore.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
NPR's "All Things Considered" examines the Obama administration's global HIV/AIDS policy. "Instead of relying on one program, such as the President's Emergency Plan for AIDS Relief or PEPFAR, [U.S. Global AIDS Coordinator Eric] Goosby says the U.S. has a new five-year strategy that would help low and middle income countries build their own health care systems that incorporate international health programs," according to NPR.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
› Verified 4 days ago
Ms. Daryl Federman, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3703 West Lake Ave, Suite 200, Glenview, IL 60026 Phone: 847-998-1188 Fax: 847-998-8008 | |
Medcare Medical Group Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1873 Waukegan Rd, Glenview, IL 60025 Phone: 847-724-7600 Fax: 847-724-7693 | |
Mark Gore, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2401 Ravine Way, Suite 100, Glenview, IL 60025 Phone: 847-724-4791 Fax: 847-998-6916 | |
Eunice Sison, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3703 W Lake Ave Ste 200, Glenview, IL 60026 Phone: 847-998-1188 | |
Pain Relief Institute, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1859 Tower Dr, Glenview, IL 60026 Phone: 847-730-3276 Fax: 847-730-3976 | |
Av Performance Therapy Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1800 Johns Dr, Glenview, IL 60025 Phone: 224-334-3075 | |
Morgan Hare, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2600 Compass Rd, Glenview, IL 60026 Phone: 877-787-3422 |